{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:58:28Z","timestamp":1785855508554,"version":"3.56.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1097\/01.wnf.0000167361.35294.da","type":"journal-article","created":{"date-parts":[[2005,6,17]],"date-time":"2005-06-17T04:01:18Z","timestamp":1118980878000},"page":"152-153","source":"Crossref","is-referenced-by-count":5,"title":["Severe Skin Reaction Related to Mycophenolate Mofetil for Myasthenia Gravis"],"prefix":"10.1097","volume":"28","author":[{"given":"Netta","family":"Levin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Mali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Karussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210203","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action.","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"R2-14-20210203","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/WNL.56.1.94","article-title":"Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases.","volume":"56","author":"Chaudhry","year":"2001","journal-title":"Neurology"},{"key":"R3-14-20210203","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/1097-4598(200008)23:8<1287::AID-MUS22>3.0.CO;2-L","article-title":"Treatment of myasthenia gravis with mycophenolate mofetil: a case report.","volume":"23","author":"Meriggioli","year":"2000","journal-title":"Muscle Nerve"},{"key":"R4-14-20210203","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1212\/WNL.51.3.912-a","article-title":"Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil.","volume":"51","author":"Hauser","year":"1998","journal-title":"Neurology"},{"key":"R5-14-20210203","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1212\/WNL.56.1.97","article-title":"Mycophenolate mofetil for myasthenia gravis: an open-label pilot study.","volume":"56","author":"Ciafaloni","year":"2001","journal-title":"Neurology"},{"key":"R6-14-20210203","first-page":"117","article-title":"Relapse of systemic lupus erythematosus in a patient receiving cyclosporine A.","volume":"15","author":"Makover","year":"1988","journal-title":"J Rheumatol"},{"key":"R7-14-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/096120339500400108","article-title":"Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature.","volume":"4","author":"Mevorach","year":"1995","journal-title":"Lupus"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.wnf.0000167361.35294.da","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:40:51Z","timestamp":1785854451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-200505000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.wnf.0000167361.35294.da","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}